[Copper metabolism disorders in vitiligo].
D000417:Albinism / Q000378:metabolism; D001327:Autoimmune Diseases; D004156:Catechol Oxidase / Q000032:analysis; D002570:Ceruloplasmin / Q000032:analysis; D002986:Clinical Trials as Topic; D003300:Copper / Q000032:analysis / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000032:analysis; D005504:Food Analysis; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications; D007408:Intestinal Absorption; D007501:Iron / Q000032:analysis; D008543:Melanins / Q000096:biosynthesis; D012867:Skin / Q000032:analysis / Q000201:enzymology / Q000378:metabolism; D014820:Vitiligo / Q000188:drug therapy / Q000378:metabolism*
D008543:Melanins; D004295:Dihydroxyphenylalanine; D003300:Copper; D007501:Iron; D004156:Catechol Oxidase; D002570:Ceruloplasmin
Les troubles du métabolisme du cuivre dans le vitiligo.